A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects

Phase 1

Amakem, NV